IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,000 | +400.0% | 228 | +293.1% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 58 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | 0.0% | 58 | 0.0% | 0.00% | – |
Q3 2020 | $3,000 | 0.0% | 58 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $3,000 | 0.0% | 58 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $3,000 | -66.7% | 58 | -61.6% | 0.00% | -50.0% |
Q4 2019 | $9,000 | -25.0% | 151 | -22.6% | 0.00% | -33.3% |
Q3 2019 | $12,000 | +200.0% | 195 | +236.2% | 0.00% | +200.0% |
Q2 2019 | $4,000 | -20.0% | 58 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,000 | +66.7% | 58 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $3,000 | -70.0% | 58 | -74.6% | 0.00% | -75.0% |
Q2 2018 | $10,000 | -54.5% | 228 | -54.4% | 0.00% | -50.0% |
Q1 2018 | $22,000 | -12.0% | 500 | 0.0% | 0.01% | -20.0% |
Q4 2017 | $25,000 | – | 500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |